7.78
price down icon1.64%   -0.13
 
loading
前日終値:
$7.91
開ける:
$7.87
24時間の取引高:
19,082
Relative Volume:
0.27
時価総額:
$439.34M
収益:
$154.57M
当期純損益:
$15.07M
株価収益率:
28.81
EPS:
0.27
ネットキャッシュフロー:
$10.92M
1週間 パフォーマンス:
+4.71%
1か月 パフォーマンス:
-2.14%
6か月 パフォーマンス:
+8.21%
1年 パフォーマンス:
+33.68%
1日の値動き範囲:
Value
$7.78
$7.90
1週間の範囲:
Value
$7.37
$7.91
52週間の値動き範囲:
Value
$5.08
$9.155

Kamada Ltd Stock (KMDA) Company Profile

Name
名前
Kamada Ltd
Name
セクター
Healthcare (1161)
Name
電話
-
Name
住所
-
Name
職員
374
Name
Twitter
Name
次回の収益日
2025-03-05
Name
最新のSEC提出書
Name
KMDA's Discussions on Twitter

KMDA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
KMDA
Kamada Ltd
7.78 439.34M 154.57M 15.07M 10.92M 0.27
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
152.82 68.32B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.66 46.55B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.85 43.80B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.33 19.01B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
306.41 13.79B 2.99B 1.21B 1.13B 25.06

Kamada Ltd Stock (KMDA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-21 開始されました The Benchmark Company Buy
2024-07-03 開始されました Stifel Buy
2018-02-02 開始されました Chardan Capital Markets Buy

Kamada Ltd (KMDA) 最新ニュース

pulisher
Jul 24, 2025

What drives Kamada Ltd. stock priceSpectacular growth rates - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Kamada Ltd. stockExceptional growth trajectory - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Kamada Ltd. a good long term investmentBreakthrough capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Kamada Ltd. stock price move sharplyHigh Potential Safe Trades - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Kamada Ltd. Stock Analysis and ForecastOutstanding yields - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 15, 2025

Why Kamada Ltd. stock attracts strong analyst attentionFree Real-Time Trading Opportunities - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Kamada Ltd. stock performs during market volatilityProfitable Yet Secure Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Emphysema Pipeline 2025: MOA, ROA, and Clinical Trial Insights - openPR.com

Jul 15, 2025
pulisher
Jul 15, 2025

Emphysema Pipeline 2025: MOA, ROA, and Clinical Trial Insights Explored by DelveInsight | Kamada, Ltd., Hoffmann-La Roche, Aeris Therapeutics, Grifols Therapeutics, Sanofi - The Globe and Mail

Jul 15, 2025
pulisher
Jul 15, 2025

Emphysema Pipeline 2025: MOA, ROA, And Clinical Trial Insights Explored By Delveinsight Kamada, Ltd., Hoffmann-La Roche, Aeris Therapeutics, Grifols Therapeutics, Sanofi - MenaFN

Jul 15, 2025
pulisher
Jul 04, 2025

Is Kamada (KMDA) Stock Undervalued Right Now? - Nasdaq

Jul 04, 2025
pulisher
Jun 20, 2025

Kamada confirms continuous business operations despite recent events in Middle East - MSN

Jun 20, 2025
pulisher
Jun 18, 2025

Should Value Investors Buy Kamada (KMDA) Stock? - Yahoo Finance

Jun 18, 2025
pulisher
Jun 17, 2025

Kamada Confirms Continuous Global Business Operations and - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Kamada Ensures Global Operations Amid Middle East Tensions - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Kamada confirms continuous business operations despite Middle East events - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Kamada Confirms No Supply Disruptions: How Israeli Biotech Giant Safeguards Global Product Availability - Stock Titan

Jun 17, 2025
pulisher
Jun 17, 2025

Plasma Therapeutics Market Revenue to Attain USD 46.46 Bn by 2033 - Precedence Research

Jun 17, 2025
pulisher
Jun 11, 2025

Kamada Reports Strong Q1 2025 Growth with Plasma Business Expansion and Key Milestones - citybuzz -

Jun 11, 2025
pulisher
Jun 10, 2025

Implied Volatility Surging for Kamada Stock Options - Yahoo Finance

Jun 10, 2025
pulisher
Jun 07, 2025

Kamada Intensifies Efforts to Highlight CYTOGAM's Role in Combatting CMV in Organ Transplant Patients - citybuzz -

Jun 07, 2025
pulisher
Jun 06, 2025

Kamada Wants To Do More For Organ Transplant Patients, Increases Efforts To Build Awareness Of Its CMV Treatment CYTOGAM - FinancialContent

Jun 06, 2025
pulisher
Jun 03, 2025

Millennium Management LLC Sells 36,872 Shares of Kamada Ltd. (NASDAQ:KMDA) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Are Investors Undervaluing Kamada (KMDA) Right Now? - Yahoo Finance

Jun 02, 2025
pulisher
May 27, 2025

Alpha-1 Antitrypsin Deficiency Market: Epidemiology, - openPR.com

May 27, 2025
pulisher
May 27, 2025

Kamada (NASDAQ:KMDA) Stock Crosses Below 200 Day Moving Average – What’s Next? - Defense World

May 27, 2025
pulisher
May 23, 2025

Kamada (NASDAQ:KMDA) Stock Rating Upgraded by Wall Street Zen - Defense World

May 23, 2025
pulisher
May 22, 2025

Kamada's (TLV:KMDA) Solid Earnings Are Supported By Other Strong Factors - simplywall.st

May 22, 2025
pulisher
May 19, 2025

Alvotech Appoints DNB Carnegie as Liquidity Provider on Nasdaq Stockholm - The Manila Times

May 19, 2025
pulisher
May 19, 2025

HC Wainwright Issues Optimistic Outlook for Kamada Earnings - Defense World

May 19, 2025

Kamada Ltd (KMDA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.93
price down icon 3.25%
$14.69
price down icon 2.20%
$9.35
price down icon 0.21%
drug_manufacturers_specialty_generic RDY
$14.71
price up icon 0.75%
$131.64
price down icon 1.51%
$306.41
price up icon 0.26%
大文字化:     |  ボリューム (24 時間):